A Phase I multicenter study of E1A gene therapy for patients with metastatic breast cancer and epithelial ovarian cancer that overexpresses HER-2/neu or epithelial ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/9721088

Hum. Gene Ther. 1998 Aug 10 9 12 1775-98

Download in:

View as

Triples

General Info

PMID
9721088